These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26637952)

  • 21. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
    Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
    Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Budesonide-hydroxypropyl-β-cyclodextrin inclusion complex in binary poloxamer 407/403 system for ulcerative colitis treatment: A physico-chemical study from micelles to hydrogels.
    Santos Akkari AC; Ramos Campos EV; Keppler AF; Fraceto LF; de Paula E; Tófoli GR; de Araujo DR
    Colloids Surf B Biointerfaces; 2016 Feb; 138():138-47. PubMed ID: 26674842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
    Liu B; Li W; Nguyen TA; Zhao J
    Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physico-chemical characterization of benzocaine-beta-cyclodextrin inclusion complexes.
    Pinto LM; Fraceto LF; Santana MH; Pertinhez TA; Junior SO; de Paula E
    J Pharm Biomed Anal; 2005 Oct; 39(5):956-63. PubMed ID: 16040222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
    Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and pharmacological evaluation of cyclodextrin complexes of etoricoxib.
    Singh I; Kumar P; Pahuja S; Tung V; Arora S
    Acta Pol Pharm; 2011; 68(2):279-84. PubMed ID: 21485302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pH on the complexation of kaempferol-4'-glucoside with three β-cyclodextrin derivatives: isothermal titration calorimetry and spectroscopy study.
    Zheng Y; Dong LN; Liu M; Chen A; Feng S; Wang B; Sun D
    J Agric Food Chem; 2014 Jan; 62(1):244-50. PubMed ID: 24308546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host-guest inclusion system of scutellarein with 2-hydroxypropyl-beta-cyclodextrin: preparation, characterization, and anticancer activity.
    Wang F; Yang B; Zhao Y; Liao X; Gao C; Jiang R; Han B; Yang J; Liu M; Zhou R
    J Biomater Sci Polym Ed; 2014; 25(6):594-607. PubMed ID: 24555409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the interactions of silibinin with 2-hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methods.
    Kellici TF; Ntountaniotis D; Leonis G; Chatziathanasiadou M; Chatzikonstantinou AV; Becker-Baldus J; Glaubitz C; Tzakos AG; Viras K; Chatzigeorgiou P; Tzimas S; Kefala E; Valsami G; Archontaki H; Papadopoulos MG; Mavromoustakos T
    Mol Pharm; 2015 Mar; 12(3):954-65. PubMed ID: 25665128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
    Zhang XN; Yan XY; Tang LH; Gong JH; Zhang Q
    Yao Xue Xue Bao; 2005 Apr; 40(4):369-72. PubMed ID: 16011270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the complexation between methylprednisolone and different cyclodextrins in solution by 1H-NMR and molecular modeling studies.
    Thi TD; Nauwelaerts K; Froeyen M; Baudemprez L; Van Speybroeck M; Augustijns P; Annaert P; Martens J; Van Humbeeck J; Van den Mooter G
    J Pharm Sci; 2010 Sep; 99(9):3863-73. PubMed ID: 20665846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C; Zoppi A; Genovese D; Longhi M
    Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex.
    Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM
    Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the inclusion behavior of chlorogenic acid with hydroxypropyl-β-cyclodextrin.
    Chao J; Wang H; Zhao W; Zhang M; Zhang L
    Int J Biol Macromol; 2012 Jan; 50(1):277-82. PubMed ID: 22115718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between epidurally and intrathecally administered sufentanil and bupivacaine in hydroxypropyl-beta-cyclodextrin in the rat.
    Meert TF; Melis W
    Acta Anaesthesiol Belg; 1992; 43(2):79-89. PubMed ID: 1385920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectral, thermal, and molecular modeling studies on the encapsulation of selected sulfonamide drugs in β-cyclodextrin nano-cavity.
    Bani-Yaseen AD; Mo'ala A
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Oct; 131():424-31. PubMed ID: 24835946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
    El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.